Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 2004 Feb;42(2):903–905. doi: 10.1128/JCM.42.2.903-905.2004

Virulence Properties and Characteristics of Shiga Toxin-Producing Escherichia coli in São Paulo, Brazil, from 1976 through 1999

T M I Vaz 1, K Irino 1, M A M F Kato 1, Â M G Dias 1, T A T Gomes 2, M I C Medeiros 3, M M M Rocha 4, B E C Guth 2,*
PMCID: PMC344473  PMID: 14766885

Abstract

Twenty-nine Shiga toxin-producing Escherichia coli (STEC) strains were identified in a collection of 2,607 isolates from patients with diarrhea in São Paulo, Brazil, from 1976 to 1999. The STEC strains belonged mainly to serotypes O111:HNM (HNM, nonmotile) (13 of 29 [44.8%]), O111:H8 (7 of 29 [24%]), and O26:H11 (4 of 29 [13.8%]); stx1 eae (26 of 29 [89.6%]), in combination with either enterohemorrhagic E. coli hlyA (11 of 26 [42%]) or astA (24 of 26 [92.3%]), prevailed. The O111 STEC strains were distinguished by their inability to decarboxylate lysine. The predominance of STEC O111 and O26 since the late 1970s and the identification of STEC serotypes O55:H19, O93:H19, and O118:H16 in association with human infections in Brazil are described for the first time.


Shiga toxin-producing Escherichia coli (STEC) can cause a broad spectrum of human illness ranging from uncomplicated diarrhea to hemorrhagic colitis (HC) and hemolytic-uremic syndrome (HUS) (14). E. coli O157:H7 is by far the most important STEC serotype in the world and has been associated with numerous outbreaks and many sporadic cases of HC and HUS (20). However, infections with other non-O157 STEC serotypes have been increasingly reported in many countries (2, 3, 22). Currently more than 100 different non-O157 STEC serotypes have been isolated from human infections. Unlike with O157:H7, outbreaks caused by non-O157 STEC have rarely been reported, and these strains have been more frequently associated with sporadic cases of diarrhea, HC, and HUS. Moreover, in many countries, non-O157 strains are more commonly isolated from patients with diarrhea or HUS than are O157 STEC strains (3, 5, 23). The major virulence trait of these bacteria is the production of one or more Stx types (Stx1, Stx2, or Stx2 variants) (20). Additional factors, produced mainly by strains in straight association with human disease and collectively referred to as enterohemorrhagic E. coli (EHEC), include intimin and enterohemolysin (1, 20). Other putative virulence factors include the enteroaggregative E. coli heat-stable enterotoxin (EAST-1), encoded by astA (25), particularly in O157:H7 and O26:H11 strains and in some other STEC serotypes. In Brazil, the studies conducted so far that searched for STEC in human diarrheal disease have investigated a limited number of strains and have described the isolation of a few non-O157 STEC strains (7, 12, 16). The isolation of O157:H7 strains from patients with bloody diarrhea as well as one with HUS related to O26:H11 infection was only recently reported in Brazil (15, 19).

The purpose of this study was to search for STEC in a collection of 2,607 E. coli isolates, most of them belonging to important serogroups increasingly associated with HUS and HC in other countries. The main virulence factors, biotypes, and susceptibility to antimicrobial agents of the STEC strains identified were characterized.

The E. coli strains studied belonged to the collection of Instituto Adolfo Lutz, a Central Public Health Laboratory in São Paulo, Brazil, and national center for E. coli serotyping, and were isolated between 1976 and 1999, mainly from children (0 to 5 years old) with diarrhea (2,549 strains); the remaining 58 E. coli strains were isolated from immunocompromised adult patients with diarrhea (mainly human immunodeficiency virus positive) over the same period. Each strain was derived from one patient. Except for diarrhea, no other information regarding the clinical aspects of the patients were available. None of the strains belonging to the enteropathogenic E. coli (EPEC) serogroups carried the EAF sequence (EPEC adherence factor) as assayed by hybridization assays with a specific DNA probe (13). The remaining strains outside the EPEC serogroups did not belong to the enteroinvasive E. coli (EIEC) serogroups, as determined by agglutination assays with specific antisera (10), and did not produce enterotoxins characteristic of the enterotoxigenic E. coli (ETEC) category (20).

The stx1, stx2, eae, EHEC hlyA, and astA sequences were sought by colony hybridization assays with specific DNA probes as described previously (13, 28). E. coli strains carrying stx1 and/or stx2 were tested for cytotoxicity activity by a Vero cell culture assay (11). The serotypes were determined by standard agglutination assays using O1 to O173 and H1 to H56 antisera (10), prepared at Institute Adolfo Lutz. Production of enterohemolysin was determined by the method of Beutin et al. (1). The detection of fermentation patterns and the lysine decarboxylation test were performed by standard methods (6, 10). The susceptibility to antimicrobial agents was determined by the standard disk diffusion method (21) using the following antibiotics (Cecon, Centro de Controle e Produtos para Diagnóstico Ltda, São Paulo, Brazil): ampicillin, amikacin, cefepime, cefoxitin, tetracycline, gentamicin, ceftazidime, ceftriaxone, imipenem, trimethoprim-sulfamethoxazole, tobramicin, kanamycin, chloramphenicol, ciprofloxacin, and streptomycin.

STEC strains were identified in 29 (1.1%) of the 2,607 E. coli strains analyzed, and the frequency varied among the different serogroups studied (Table 1). Most (27 of 29 [93%]) of the STEC strains were isolated from children (45% from infants aged 0 to 12 months and 34% from children aged 1 to 5 years), but two of them were from adults. The STEC strains belonged mainly to serotypes O111:HNM (13 of 29 [44.8%]), O111:H8 (7 of 29 [24%]), and O26:H11 (4 of 29 [13.8%]), but serotypes O55:H19, O93:H19, O118:H16, and O157:H7 (one strain each) were also detected (Table 2). The great majority of the strains (93%) harbored stx1, while the only O157:H7 strain carried stx2, and the stx1 stx2 genotype was observed in the O93:H19 strain. Cytotoxin production was confirmed in all strains containing stx. Except for two strains, all the others carried eae, and the EHEC hlyA gene was identified in 13 (44.8%) of the 29 strains. Moreover, it could be observed that STEC strains were isolated in 1976 and in subsequent years, but no predominance in a particular year was identified (Table 2). Analysis of the biochemical behavior of the STEC strains showed that all O111 STEC strains fail to decarboxylate lysine whereas this reaction was positive in the other serotypes identified. Moreover, lack or delay in fermenting sucrose was observed only in serogroup O111. All strains except the O157 strain fermented sorbitol, and inability to ferment rhamnose and dulcitol was associated with O26 and O118 strains, which were also the only ones that fermented sorbose. Resistance to at least one drug was identified in 51.7% of the STEC strains, and occurred among strains of serogroups O26 (2 strains), O111 (12 strains), and O118 (1 strain). However, multidrug resistance (to three to six drugs) was observed only in serotypes O111:HNM (four strains) and O111:H8 (one strain). The antibiotics for which resistance was most frequently observed were tetracycline (93%), streptomycin (73%), kanamycin (33%), chloramphenicol (20%), and trimethoprim-sulfamethoxazole (13%) (either alone or in combination).

TABLE 1.

Frequency of STEC among several E. coli serogroups isolated from patients with diarrheal disease in São Paulo, Brazil, from 1976 to 1999

Serogroupa No. of strains studied No. (%) of STEC strains
O26 205 4 (1.95)
O55 209 1 (0.48)
O111 802 21 (2.61)
O113 16 0
O119 305 0
O157 15 1 (6.67)
ND 1,055 2 (0.19)
Total 2,607 29 (1.1%)
a

ND, undetermined (not belonging to the EPEC, EIEC, and ETEC categories).

TABLE 2.

Serotypes, virulence markers, and year of isolation of STEC strains isolated in São Paulo, Brazil

Serotype (no. of strains) stx gene type Presence of (no. of strains):
Presence of EHEC Hly (no. of strains) Yr of isolation (no. of strains)
eae EHEC hlyA astA
O26:H11 (4) 1 + + + + 1981, 1985, 1987, 1997
O55:H19 (1) 1 1984
O93:H19 (1) 1 + 2 + + 1984
O111:NM (13) 1 + + (3) + (12) + (3) 1978 (3), 1980 (2), 1981, 1983, 1985, 1986, 1987, 1988 (2), 1993
O111:H8 (7) 1 + + (3) + (6) + (2) 1976, 1977, 1979, 1985, 1988, 1993, 1998
O111:H11 (1) 1 + + 1981
O118:H16a (1) 1 + + + + 1989
O157:H7a (1) 2 + + + + 1990
a

Isolated from adults.

In the present study we observed the predominance of O111 and O26 serotypes among STEC strains identified in São Paulo from 1976 through 1999 and described for the first time the association of other serotypes such as O55:H19, O93:H19, and O118:H16 with human infections in Brazil. The great majority of these non-O157 serotypes are among those most frequently isolated in many different countries (2, 9, 14, 23). In São Paulo, low rates of occurrence O111 STEC strains had previously been reported (16). Although outbreaks of HUS caused by O111 strains had been described (4, 5, 8), the O111 STEC strains identified so far in our settings were all associated with sporadic cases of diarrhea in young children. Moreover, the results of this retrospective study and the recent description of the isolation of a STEC O26:H11 strain associated with HUS (15) are in contrast to previous reports that described the nonoccurrence of STEC among O26 strains in Brazil (24, 26, 27).

In many developed countries, O157:H7 is the most prevalent STEC serotype associated with severe disease in humans (14, 22). However, estimation of the prevalence of O157-associated infections in Brazil is difficult since screening for O157 is performed by only a few microbiological laboratories. The only O157:H7 strain found in the present study, isolated in 1990 from a human immunodeficiency virus-positive patient, and the two other O157:H7 strains that we recently isolated in São Paulo are the only O157:H7 strains identified so far in association with human disease in Brazil (19).

In this study stx1 eae prevailed, and an association between eae and EHEC hlyA was seen among strains of serotypes O26:H11, O111:H8, O111:NM, O118:H16, and O157:H7. Thus, considering the serotypes and virulence profiles, these STEC strains can be classified as EHEC, and it would not be surprising if some of them had been associated with more severe diseases. We can only speculate about this possibility, because of the retrospective character of the present study and because detailed clinical data for the patients are not available.

With regard to the biochemical behavior of the STEC strains, besides confirming that all STEC O111 strains were lysine decarboxylase negative, as previously reported by Guth et al. (16, 17), we observed that this reaction also distinguished O111 STEC strains from the other STEC serotypes identified. The inability to decarboxylate lysine and the lack of sucrose fermentation by the majority of the O111:HNM strains showed that these strains can be misidentified presumptively as EIEC or as Shigella. The inability to ferment rhamnose was recently reported as a characteristic of O26 STEC isolates (18). Nevertheless, among the strains presently identified, O118 as well as O26 was rhamnose negative. In conclusion, the results of this study showed that potential EHEC strains, particularly O111 and O26 strains, have been found in São Paulo since the late 1970s. The implementation of a systematic surveillance of bloody diarrhea and HUS in Brazil will contribute to estimations of the real association of O157:H7 and non-O157 strains with human infections.

Acknowledgments

We thank Mônica A. M. Vieira for her technical assistance with the hybridization assays.

This work was supported by grants from Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) no. 01/07921-7 and Conselho Nacional de Desenvolvimento Científico e Tecnológico, CNPq, Brasilia, Brazil.

REFERENCES

  • 1.Beutin, L., M. A. Montenegro, I. Ørskov, F. Ørskov, J. Prada, S. Zimmerman, and R. Stephan. 1989. Close association of verotoxin (Shiga-like toxin) production with enterohemolysin production in strains of Escherichia coli. J. Clin. Microbiol. 27:2559-2564. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Beutin, L., S. Zimmermann, and K. Gleiser. 1998. Human infections with Shiga toxin-producing Escherichia coli other than serogroup O157 in Germany. Emerg. Infect. Dis. 4:635-639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Boelin, P., S. A. Mcewen, F. Boelin-Petzold, J. B. Wilson, R. P. Johnson, and C. L. Gyles. 1999. Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans. J. Clin. Microbiol. 37:497-503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Boudailliez, B., P. Berquin, P. Mariani-Kurkdjian, D. Ilef, B. Cuvelier, I. Capek, B. Tribout, E. Bingen, and C. Piussan. 1997. Possible person-to-person transmission of Escherichia coli O111-associated hemolytic uremic syndrome. Pediatr. Nephrol. 11:36-39. [DOI] [PubMed] [Google Scholar]
  • 5.Cameron, A. S., M. Y. Beers, C. C. Walker, N. Rose, E. Anear, Z. Manatakis, K. Kirk, I. Calder, F. Jenkins, P. N. Goldwater, A. Paton, J. Paton, K. Jureidini, A. Hoffman, P. Henning, D. Hansman, A. Lawrence, R. Miller, R. Ratcliff, R. Doyle, C. Murray, D. Davos, P. Cameron, J. Seymour-Murray, I. I. im, J. Lanser, L. Selvey, and S. Beaton. 1995. Community outbreak of hemolytic uremic syndrome attributable to Escherichia coli O111:NM—South Australia. Morb. Mortal. Wkly. Rep. 44:550-558. [PubMed] [Google Scholar]
  • 6.Camguilhem, R., and A. Milon. 1989. Biotypes and O serogroups of Escherichia coli involved in intestinal infections of weaned rabbits: clues to diagnosis of pathogenic strains. J. Clin. Microbiol. 27:743-747. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Cantarelli, V., K. Nagayama, A. Takahashi, T. Honda, P. F. Cauduro, C. A. G. Dias, A. Mezzari, and T. Brodt. 2000. Isolation of Shiga toxin-producing Escherichia coli (STEC) serotype O91:H21 from a child with diarrhea in Porto Alegre city, RS, Brazil. Braz. J. Microbiol. 31:266-270. [Google Scholar]
  • 8.Caprioli, A., I. Luzzi, F. Rosmini, C. Resti, A. Edefonti, F. Perfumo, C. Farina, A. Goglio, A. Gianviti, and G. Rizzoni. 1994. Communitywide outbreak of hemolytic-uremic syndrome associated with non-O157 verocytotoxin-producing Escherichia coli. J. Infect. Dis. 169:208-211. [DOI] [PubMed] [Google Scholar]
  • 9.Caprioli, A., and E. Tozzi. 1998. Epidemiology of Shiga toxin-producing Escherichia coli infections in continental Europe, p. 38-48. In J. B. Kaper and A. D. O'Brien (ed.), Escherichia coli O157:H7 and other Shiga toxin-producing E. coli strains. American Society for Microbiology, Washington, D.C.
  • 10.Ewing, W. H. 1999. Edwards & Ewing's identification of Enterobacteriaceae, 4th ed. Elsevier Science Publishers, New York, N.Y.
  • 11.Gentry, M. K., and J. M. Dalrymple. 1980. Quantitative microtiter cytotoxicity assay for Shigella toxin. J. Clin. Microbiol. 12:361-366. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Giraldi, R., B. E. C. Guth, and L. R. Trabulsi. 1990. Production of Shiga-like toxin among Escherichia coli strains and other bacteria isolated from diarrhea in São Paulo, Brazil. J. Clin. Microbiol. 28:1460-1462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Gonçalves, A. G., L. C. Campos, T. A. T. Gomes, J. Rodrigues, V. Sperandio, T. S. Whittam, and L. R. Trabulsi. 1997. Virulence properties and clonal structures of strains of Escherichia coli O119 serotypes. Infect. Immun. 65:2034-2040. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Griffin, P. M., and R. V. Tauxe. 1991. The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome. Epidemiol. Rev. 13:60-98. [DOI] [PubMed] [Google Scholar]
  • 15.Guth, B. E. C., R. L. Souza, T. M. I. Vaz, and K. Irino. 2002. First Shiga toxin-producing Escherichia coli isolate from a patient with hemolytic uremic syndrome, Brazil. Emerg. Infect. Dis. 8:535-536. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Guth, B. E. C., S. R. T. S. Ramos, A. M. F. Cerqueira, J. R. C. Andrade, and T. A. T. Gomes. 2002. Phenotypic and genotypic characteristics of Shiga toxin-producing Escherichia coli strains isolated from children in São Paulo, Brazil. Mem. Inst. Oswaldo Cruz 97:1085-1089. [DOI] [PubMed] [Google Scholar]
  • 17.Guth, B. E. C., T. A. T. Gomes, T. M. I. Vaz, and K. Irino. 2003. Inability to decarboxylate lysine as a presumptive marker to identify Shiga toxin-producing Escherichia coli strains of serogroup O111. J. Clin. Microbiol. 41:3450. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Hiramatsu, R., M. Matsumoto, Y. Miwa, Y. Suzuki, M. Saito, and Y. Miyazaki. 2002. Characterization of Shiga toxin-producing Escherichia coli O26 strains and establishment of selective isolation media for these strains. J. Clin. Microbiol. 40:922-925. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Irino, K., T. M. I. Vaz, M. A. M. F. Kato, Z. V. F. Naves, R. R. Lara, M. E. C. Marco, M. M. Rocha, T. P. Moreira, T. A. T. Gomes, and B. E. C. Guth. 2002. O157:H7 Shiga toxin-producing Escherichia coli strains associated with sporadic cases of diarrhea in São Paulo, Brazil. Emerg. Infect. Dis. 8:446-447. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Nataro, J. P., and J. B. Kaper. 1998. Diarrheagenic Escherichia coli. Clin. Microbiol. Rev. 11:142-201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.National Committee for Clinical Laboratory Standards. 1997. Performance standards for antimicrobial susceptibility testing, 6th ed. Approved standard M2-A6. NCCLS, Villanova, Pa.
  • 22.Paton, J. C., and A. W. Paton. 1998. Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections. Clin. Microbiol. Rev. 11:450-470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Pradel, N., V. Livrelli, C. Champs, J. B. Palcoux, A. Reynaud, F. Scheutz, J. Sirot, B. Joly, and C. Forestier. 2000. Prevalence and characterization of Shiga toxin-producing Escherichia coli isolated from cattle, food, and children during a one-year prospective study in France. J. Clin. Microbiol. 38:1023-1031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Saridakis, H. O. 1994. Non production of Shiga-like toxins by Escherichia coli serogroup O26. Rev. Microbiol. São Paulo 25:154-155. [Google Scholar]
  • 25.Savarino, S. J., A. McVeigh, J. Watson, J. Molina, A. Cravioto, P. Echeverria, M. K. Bhan, M. M. Levine, and A. Fasano. 1996. Enteroaggregative Escherichia coli heat-stable enterotoxin is not restricted to enteroaggregative Escherichia coli. J. Infect. Dis. 173:1019-1022. [DOI] [PubMed] [Google Scholar]
  • 26.Silva, M. L. M., I. C. A. Scaletsky, and L. H. Vidotto. 1983. Non production of Shiga-like toxin among enteropathogenic strains of Escherichia coli isolated in São Paulo, Brasil. Rev. Microbiol. São Paulo 14:161-162. [Google Scholar]
  • 27.Trabulsi, L. R., L. C. Campos, T. S. Whittam, T. A. T. Gomes, J. Rodrigues, and A. Z. Gonçalves. 1996. Traditional and nontraditional enteropathogenic Escherichia coli serogroups. Rev. Microbiol. São Paulo 27:1-6. [Google Scholar]
  • 28.Yamamoto, T., and M. Nakazawa. 1997. Detection and sequences of the enteroaggregative Escherichia coli heat-stable enterotoxin 1 gene in enterotoxigenic E. coli strains isolated from piglets and calves with diarrhea. J. Clin. Microbiol. 65:3478-3484. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES